Embark is a provider of dog DNA tests and developer of a powerful platform for scientific discovery designed to accelerate advancements in personalized dog care.
| Date | Funding Round | Funding Raised | Price per Share | IPO Valuation |
|---|---|---|---|---|
| 7/26/2021 | Series B | $759.47MM | $XXX.XX | $XXX.XX |
| 4/11/2019 | Series A-1 and A-2 | $55.47MM | $XXX.XX | $XXX.XX |
| 7/18/2017 | Series Seed-1 and Seed-2 | $15.1MM | $XXX.XX | $XXX.XX |
| 5/31/2016 | Series Seed-3 and Seed-4 | $10.98MM | $XXX.XX | $XXX.XX |
